Page 37 - GTM-4-1
P. 37

Global Translational Medicine                                   Phytonanotherapy in cancer and diabetes care



            therapeutic effectiveness while minimizing negative effects.   Author contributions
            Additional study on NP-based drug delivery systems will
            lead to more efficient and precise targeting of malignant   Conceptualization: Faheem Patwekar
            cells or specific diabetic areas. These advancements may   Investigation: Faheem Patwekar, Mohsina Patwekar
            result in improved therapeutic efficacy and less systemic   Writing – original draft: Faheem Patwekar, Mohsina
            toxicity. As NPs and biosensors evolve, they will provide   Patwekar
            more  sensitive  and  specialized  diagnostic  instruments.   Writing – review & editing: All authors
            Early cancer and diabetes identification, as well as real-  Ethics approval and consent to participate
            time monitoring of therapy responses, will become more
            practical. By combining CAM concepts with NP-based   Not applicable.
            therapies, innovative combination treatments may be
            developed. These medicines may combine the benefits   Consent for publication
            of  traditional  therapy  with  cutting-edge  nanomedicine,   Not applicable.
            allowing for more holistic  approaches to cancer  and
            diabetes control. 96                               Availability of data

              As research advances and the safety and efficacy   Not applicable.
            of these therapies are confirmed, regulatory agencies
            may approve and  regulate  CAM-based NP  medicines,   References
            giving patients access to alternative and complementary   1.   Fuad NF, Ching SM, Dzulkarnain DH, Cheong AT,
            treatments in addition to traditional choices. Future   Zakaria  ZA.  Complementary  alternative  medicine  use
            health care may priorities patient-centered care,     among postpartum mothers in a primary care setting:
            delivering a range of treatment options that match with   A cross-sectional study in Malaysia. BMC Complement Med
            individual ideas and values, with a focus on patient   Ther. 2020;20:197.
            preferences and overall well-being. Efforts to promote the      doi: 10.1186/s12906-020-02984-7
            eco-friendliness and cost-effectiveness of these therapies
            may make them more accessible, especially in resource-  2.   Frawley JE, McKenzie K, Janosi J, Forssman B, Sullivan E,
            limited places where CAM and sustainable treatments   Wiley K. The role of complementary and alternative medicine
                                                                  practitioners in the information‐seeking pathway of vaccine‐
            are popular. Continued developments in green synthesis   hesitant parents in the Blue Mountains area, Australia.
            processes will increase the efficiency and scalability of NP   Health Soc Care Community. 2021;29(6):e368-e376.
            manufacturing, making these medicines more realistic
            for wider clinical usage. Educating the general public      doi: 10.1111/hsc.13361
            and healthcare professionals on the benefits, risks, and   3.   Upamali S, Rathnayake S. Perspectives of older people
            possibilities  of  CAM,  phytonanotherapy,  and  NP-based   with uncontrolled type  2 diabetes mellitus towards
            treatments will be critical for making informed treatment   medication adherence: A  qualitative study.  PLoS  One.
            decisions. 97-101                                     2023;18(8):e0289834.
              Overall, integrating CAM, phytonanotherapy, and NPs      doi: 10.1371/journal.pone.0289834
            in cancer and diabetes treatment offers great promise,   4.   Kristoffersen AE, Nilsen JV, Stub T,  et al. Use of
            providing patients with a varied range of options and   Complementary and Alternative Medicine in the context of
            contributing to more effective, sustainable, and patient-  cancer; prevalence, reasons for use, disclosure, information
            centered health care. However, further research, rigorous   received, risks and benefits reported by people with cancer
            clinical trials, and regulatory backing will be required to   in Norway. BMC Complement Med Ther. 2022;22(1):202.
            fully realize the potential of these novel treatments.     doi: 10.1186/s12906-022-03606-0

            Acknowledgments                                    5.   Vijayakumar  S,  Vinayagam  R,  Anand  MA,  et al.  Green
                                                                  synthesis of gold nanoparticle using  Eclipta alba  and
            None.                                                 its  antidiabetic  activities  through regulation of Bcl-2
                                                                  expression in pancreatic cell line. J Drug Deliv Sci Technol.
            Funding                                               2020;58:101786.
            None.                                                 doi: 10.1016/j.jddst.2020.101786

            Conflict of interest                               6.   Singh H, Desimone MF, Pandya S,  et al. Revisiting the
                                                                  green synthesis of nanoparticles: Uncovering influences of
            The authors declare they have no competing interests.  plant extracts as reducing agents for enhanced synthesis


            Volume 4 Issue 1 (2025)                         29                              doi: 10.36922/gtm.5840
   32   33   34   35   36   37   38   39   40   41   42